Antiphospholipid syndrome
DOI:
https://doi.org/10.11606/issn.2176-7262.v31i2p305-315Keywords:
Antibodies, Antiphospholipid. Antibodies, Anticardiolipin. Lupus Coagulation. Inhibitor. Lupus Erythematosus Systemic. Thrombosis.Abstract
The antiphosfolipide syndrome (APS) was recently described and is associated with arterial and venous thrombosis, repeated abortions, thrombocypoenia and, less frequently, with autoimmune hemolitic anemia and cutaneous, cardiac or neurologic manifestations. This review discusses pathophysiology, clinical presentation and treatment of APS and includes an analysis of 69 cases seen in our clinic.
Downloads
Download data is not yet available.
Downloads
Published
1998-06-30
Issue
Section
Artigo Especial: Imunologia Clínica
License
Copyright (c) 1998 Paulo Louzada Junior, Selvio Machado Simon, Júlio C. Voltarelli, Eduardo A. Donadi
This work is licensed under a Creative Commons Attribution 4.0 International License.
How to Cite
1.
Louzada Junior P, Simon SM, Voltarelli JC, Donadi EA. Antiphospholipid syndrome. Medicina (Ribeirão Preto) [Internet]. 1998 Jun. 30 [cited 2024 May 17];31(2):305-1. Available from: https://www.revistas.usp.br/rmrp/article/view/7677